MFSD8

 

Full name: major facilitator superfamily domain containing 8 Alias Symbol: MGC33302
Type: protein-coding gene Cytoband: 4q28.2
Entrez ID: 256471 HGNC ID: HGNC:28486 Ensembl Gene: ENSG00000164073 OMIM ID: 611124
Drug and gene relationship at DGIdb

 

Expression of MFSD8:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 MFSD8 256471 229509_at -0.1409 0.7268
GSE26886 MFSD8 256471 229509_at -0.4854 0.0431
GSE45670 MFSD8 256471 229509_at -0.0304 0.8206
GSE53622 MFSD8 256471 11492 -0.4251 0.0000
GSE53624 MFSD8 256471 93757 -0.2320 0.0007
GSE63941 MFSD8 256471 229509_at -0.1800 0.6839
GSE77861 MFSD8 256471 229509_at 0.0018 0.9930
GSE97050 MFSD8 256471 A_23_P30162 0.0826 0.7898
SRP007169 MFSD8 256471 RNAseq 0.2989 0.4459
SRP008496 MFSD8 256471 RNAseq 0.3081 0.2689
SRP064894 MFSD8 256471 RNAseq -0.3293 0.0655
SRP133303 MFSD8 256471 RNAseq 0.0390 0.7770
SRP159526 MFSD8 256471 RNAseq -0.3805 0.1236
SRP193095 MFSD8 256471 RNAseq -0.4241 0.0000
SRP219564 MFSD8 256471 RNAseq -0.2216 0.5186
TCGA MFSD8 256471 RNAseq -0.1834 0.0017

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by MFSD8 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of MFSD8:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 MFSD8 256471 0 12 18
GSE20123 MFSD8 256471 0 12 18
GSE43470 MFSD8 256471 0 13 30
GSE46452 MFSD8 256471 1 36 22
GSE47630 MFSD8 256471 0 22 18
GSE54993 MFSD8 256471 9 0 61
GSE54994 MFSD8 256471 1 11 41
GSE60625 MFSD8 256471 0 1 10
GSE74703 MFSD8 256471 0 11 25
GSE74704 MFSD8 256471 0 6 14
TCGA MFSD8 256471 8 36 52

Total number of gains: 19; Total number of losses: 160; Total Number of normals: 309.  


 

Somatic mutations of MFSD8:

 

Generating mutation plots.

 

Highly correlated genes for MFSD8:

 

Showing all 5 correlated genes with mean PCC>0.5.

Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
MFSD8CEP1350.593532303
MFSD8CYP2J20.567098303
MFSD8RABGGTB0.56623403
MFSD8DNASE10.553447303
MFSD8RANBP20.544198504

For details and further investigation, click here